Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/02/2000WO2000041726A3 Noninvasive vascular therapy
11/02/2000WO2000041528A3 Improved controlled release compositions and method
11/02/2000WO2000041516A3 Reagents and methods useful for detecting diseases of the breast
11/02/2000WO2000041482A3 Oral administration of taxoid derivatives
11/02/2000WO2000041478A3 Agglomerates by crystallisation
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040699A3 Astrocytes, their preparation and uses thereof
11/02/2000WO2000040584A3 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000WO2000040272A3 P450 / acetaminophen gdept for cancer treatment
11/02/2000WO2000040271A3 P450 / acetaminophen gdept for cancer treatment
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039143A3 Antiviral nucleoside analogues
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000039130A3 Prenyl transferase inhibitors
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000038626A3 Substrate composition and method of use for sequestration of skin irritants
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037469B1 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000WO2000037464A3 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
11/02/2000WO2000037093A8 Bone resorption inhibitors
11/02/2000WO2000035408A3 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
11/02/2000WO2000033878A3 Stabilization of macrolides
11/02/2000WO2000033161A3 Methods to reduce variance in treatment studies using genotyping
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000WO2000029029A9 Compositions and methods for producing vascular occlusion
11/02/2000WO2000028985A9 Method of treating seizure disorders
11/02/2000WO2000028061A9 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
11/02/2000WO2000012508B1 Pyrrolbenzodiazepines
11/02/2000WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage
11/02/2000WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1048673A1 Neovascularization inhibitor containing dienogest as the active ingredient
11/02/2000EP1048668A2 Process for preparing spray granules containing riboflavin
11/02/2000EP1048667A1 Process for preparing 8-cyclopentyl-6-ethyl-3-(substituted)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacenes and intermediates useful therein
11/02/2000EP1048661A2 Process for preparing anti-osteoporotic agents
11/02/2000EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
11/02/2000EP1048640A1 Apoptosis inhibitors
11/02/2000EP1048297A2 Use of polyethylene glycol for reducing of intestinal gas, cramping and anorectal irritation
11/02/2000EP1048296A1 Drugs augmenting nkt cells
11/02/2000EP1048295A2 Pharmaceutical compositions comprising co-micronized fenofibrate
11/02/2000EP1048294A2 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
11/02/2000EP1048292A2 Stable combination of active agents containing surface-active gucose derivatives and hydroxycarboxylic acids
11/02/2000EP1048288A1 Use of halogenated antimycotic- and cationic antibacterial-compounds for the treatment of skin redness and/or cutaneous disorders induced by malassezia spp
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047774A1 Methods and compositions for gene delivery
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047703A1 A combinatorial library of moenomycin analogs and methods of producing same
11/02/2000EP1047701A1 Mitochondrially targeted antioxidants
11/02/2000EP1047699A1 Platelet adp receptor inhibitors
11/02/2000EP1047698A1 Piperazino derivatives as neurokinin antagonists
11/02/2000EP1047697A1 Triazolo-pyridazine derivatives as ligands for gaba receptors
11/02/2000EP1047695A1 Novel bispidine antiarrhythmic compounds
11/02/2000EP1047694A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
11/02/2000EP1047692A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof and methods of treating bacterial and microbial infections with these inhibitors
11/02/2000EP1047691A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists
11/02/2000EP1047690A1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
11/02/2000EP1047688A1 Thiophene nitrone compounds
11/02/2000EP1047686A1 Substituted bicyclic lactones
11/02/2000EP1047685A1 Substituted beta,gamma-anellated lactones
11/02/2000EP1047684A1 Substituted alpha,beta-anellated butyrolactones
11/02/2000EP1047683A1 Thioether furan nitrone compounds
11/02/2000EP1047682A1 Recovery of taxanes from plant material
11/02/2000EP1047678A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
11/02/2000EP1047676A1 Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047673A1 Novel heterocyclic compounds
11/02/2000EP1047670A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels
11/02/2000EP1047668A1 Triazepinones, process for their preparation and their therapeutic application
11/02/2000EP1047665A1 Matrix metalloprotease inhibitors
11/02/2000EP1047664A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
11/02/2000EP1047663A1 A NOVEL PHOSPHATE SALT OF ISOPROPYL-METHYL- 2-(3-n-PROPOXYPHENOXY)ETHYL]AMINE
11/02/2000EP1047656A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors
11/02/2000EP1047471A1 Systems and methods for local delivery of an agent
11/02/2000EP1047456A1 A method and composition for cancer treatment by enzymatic conversion of soluble radioactive toxic agents
11/02/2000EP1047450A1 Ace inhibitor-mmp inhibitor combinations
11/02/2000EP1047440A1 St. john's wort and methyl donor composition and uses thereof
11/02/2000EP1047436A2 Methods of treating tardive dyskinesia and other movement disorders
11/02/2000EP1047434A2 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
11/02/2000EP1047433A1 Cellulose derivatives and colorectal cancer risk reduction
11/02/2000EP1047432A1 Drug-directed mutagenesis/drug-driven selection for lethal mutants
11/02/2000EP1047431A1 Pharmaceutically active compounds and methods of use thereof
11/02/2000EP1047429A1 The use of brinzolamide to prevent visual field loss
11/02/2000EP1047428A1 Pharmaceutically active morpholinol
11/02/2000EP1047427A1 Combination of a gaba-a alpha 2/3 agonist and a selective serotonin reuptake inhibitor
11/02/2000EP1047426A1 Use of methylnaltrexone and related compounds
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047424A1 Il-8 receptor antagonists
11/02/2000EP1047423A1 Novel apoptosis inhibitors
11/02/2000EP1047422A1 Use of histamine for elevating blood histamine levels
11/02/2000EP1047421A2 Inhibition of lipoprotein oxidation
11/02/2000EP1047420A1 Modulation of hair growth
11/02/2000EP1047419A1 Methods for treating diabetic dyslipidemia using tocotrienols
11/02/2000EP1047418A1 Inhibition of raf kinase using substituted heterocyclic ureas
11/02/2000EP1047417A2 Vanadium (iv) metallocene complexes having spermicidal activity
11/02/2000EP1047416A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
11/02/2000EP1047415A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
1 ... 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 6233 6234 6235 6236 6237 ... 7860